Patents by Inventor Guido Hanauer

Guido Hanauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of idiopathic pulmonary fibrosis
    Patent number: 11690839
    Abstract: The present invention is directed to the treatment of idiopathic pulmonary fibrosis with (a) a phosphodiesterase 4 inhibitor or (b) a phosphodiesterase 4 inhibitor and a second active pharmaceutical ingredient.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: July 4, 2023
    Assignee: TAKEDA GMBH
    Inventors: Guido Hanauer, Sham Nikam, Masatoshi Hazama
  • Treatment of nonalcoholic fatty liver disease
    Patent number: 11179384
    Abstract: The present invention is directed to methods for the treatment of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steato-hepatitis (NASH) with a phosphodiesterase 4 (PDE4) inhibitor.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: November 23, 2021
    Assignee: TAKEDA GMBH
    Inventors: Guido Hanauer, Hiroshi Nagabukuro, Yuichiro Amano
  • TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
    Publication number: 20210283122
    Abstract: The present invention is directed to methods for the treatment of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steato-hepatitis (NASH) with a phosphodiesterase 4 (PDE4) inhibitor.
    Type: Application
    Filed: August 25, 2017
    Publication date: September 16, 2021
    Inventors: Guido HANAUER, Hiroshi NAGABUKURO, Yuichiro AMANO
  • TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20210113549
    Abstract: The present invention is directed to the treatment of idiopathic pulmonary fibrosis with (a) a phosphodiesterase 4 inhibitor or (b) a phosphodiesterase 4 inhibitor and a second active pharmaceutical ingredient.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 22, 2021
    Inventors: Guido HANAUER, Sham NIKAM, Masatoshi HAZAMA
  • TREATMENT OF DIABETIC NEPHROPATHY
    Publication number: 20200179369
    Abstract: The present invention is directed to the treatment of diabetic nephropathy with a) a phosphodiesterase 4 inhibitor, b) a combination of a phosphodiesterase 4 inhibitor with an AT1 angiotensin II receptor antagonist or c) a combination of a phosphodiesterase 4 inhibitor with an angiotensin-converting enzyme inhibitor.
    Type: Application
    Filed: July 28, 2016
    Publication date: June 11, 2020
    Inventors: Guido HANAUER, Stephanie VOLLERT, Masatoshi HAZAMA, Takanori MATSUO
  • Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions
    Patent number: 10495630
    Abstract: A method for selecting a compound or a composition suitable for treating lipofuscin associated diseases in a patient, the method including the steps of determining a reactivity factor, determining a targeting factor that allows an uptake into a cell and a provides a targeting of lipofuscin, and selecting a compound or a composition or combining compounds to obtain a compound or composition that comprises a reactivity factor and an targeting factor.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: December 3, 2019
    Assignees: KATAIRO GMBH, TAKEDA GMBH
    Inventors: Ulrich Schraermeyer, Michael Burnet, Jörg Senn-Bilfinger, Ernst Sturm, Guido Hanauer
  • Treatment of Partly Controlled or Uncontrolled Severe Asthma
    Publication number: 20160339010
    Abstract: Method for the treatment of partly controlled or uncontrolled severe asthma comprising administering either a) a phosphodiesterase 4 (PDE4) inhibitor or b) a phosphodiesterase 4 (PDE4) inhibitor and a leukotriene modifier as add-on to standard of care in severe asthma.
    Type: Application
    Filed: January 20, 2015
    Publication date: November 24, 2016
    Applicant: TAKEDA GMBH
    Inventors: Guido HANAUER, Hermann TENOR
  • Roflumilast for the treatment of diabetes mellitus type 2
    Patent number: 8541456
    Abstract: The application relates to specific combinations of Roflumilast and/or Roflumilast N-Oxide and a PPAR-agonist, as well as their use in the treatment of diabetes mellitus type 2.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: September 24, 2013
    Assignee: Takeda GmbH
    Inventors: Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Beate Schmidt, Dirk Bredenbröker, Wilhelm Wurst, Jörg Kemkowski
  • ROFLUMILAST FOR THE TREATMENT OF DIABETES MELLITUS
    Publication number: 20110269750
    Abstract: The application relates to specific combinations of Roflumilast and/or Roflumilast N-Oxide and a PPAR-agonist, as well as their use in the treatment of diabetes mellitus type 2.
    Type: Application
    Filed: July 11, 2011
    Publication date: November 3, 2011
    Applicant: NYCOMED GMBH
    Inventors: Hans-Peter KLEY, Guido HANAUER, Daniela HAUSER, Beate SCHMIDT, Dirk BREDENBRÖKER, Wilhelm WURST, Jörg KEMKOWSKI
  • Roflumilast for the treatment of diabetes mellitus
    Patent number: 8017633
    Abstract: The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: September 13, 2011
    Assignee: Nycomed GmbH
    Inventors: Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Beate Schmidt, Dirk Bredenbroeker, Wilhelm Wurst, Joerg Kemkowski
  • Salt of (S)-pantoprazole and its hydrates
    Patent number: 7629361
    Abstract: The invention relates to (?)-pantoprazole magnesium and its hydrates and to medicaments comprising these compounds.
    Type: Grant
    Filed: July 26, 2003
    Date of Patent: December 8, 2009
    Assignee: NYCOMED GmbH
    Inventors: Wolfgang Kromer, Bernd Müller, Stefan Postius, Wolfgang-Alexander Simon, Ernst Sturm, Guido Hanauer
  • Roflumilast for the Treatment of Diabetes Mellitus
    Publication number: 20080214625
    Abstract: The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.
    Type: Application
    Filed: March 3, 2006
    Publication date: September 4, 2008
    Applicant: KONINKLIJKE HILIPS ELECTRONICS, N.V.
    Inventors: Hans-Peter Kley, Guido Hanauer, Daniela Hauser, Beate Schmidt, Dirk Bredenbroker, Wilhelm Wurst, Jorg Kemkowski
  • Novel combination for the treatment of airway disorders
    Publication number: 20050222193
    Abstract: The invention relates to the combination of reversible proton pump inhibitors and airway therapeutics for the treatment of airway disorders.
    Type: Application
    Filed: May 3, 2003
    Publication date: October 6, 2005
    Inventors: Guido Hanauer, Wolfgang Kromer, Stefan Postius, Wolfgang-Alexander Simon
  • Combination for the treatment of airway disorders
    Publication number: 20050165041
    Abstract: The invention relates to the combination of proton pump inhibitors and airway therapeutics for the treatment of airway disorders.
    Type: Application
    Filed: May 3, 2003
    Publication date: July 28, 2005
    Applicant: Altana Pharma AG
    Inventors: Guido Hanauer, Wolfgang Kromer, Stefan Postius, Wolfgang-Alexander Simon
  • Salt of (s)-pantoprazole and its hydrates
    Publication number: 20040248940
    Abstract: The invention relates to (−)-pantoprazole magnesium and its hydrates and to medicaments comprising these compounds.
    Type: Application
    Filed: March 15, 2004
    Publication date: December 9, 2004
    Inventors: Wolfgang Kromer, Bernd Muller, Stefan Postius, Wolfgang-Alexander Simon, Ernst Sturm, Guido Hanauer